The nominating institution FMP on the breakthrough: Christian Hackenberger has pioneered contributions to the development of protein-based therapeutics, based on the chemical modification and cellular delivery of antibodies to target cancer and viral infections. Highlights include the engineering of an inhibitor against human and avian influenza, and safer next-gen antibody…
Login or Register
You need to be logged in to use this feature.
Further Activities to have a look at